Mayo Clinic
Rochester, Minnesota, 55905, United States
Location status: Recruiting
Location contact
Nicole Ron
CONTACT
Sally Olmstead
CONTACT
NCT Number: NCT07829692
The purpose of this research is to assess the impact of an eight-week home cadence training program on stress urinary incontinence symptoms in parous women.
Interested in participating?
Request Info18 year and older
Female
Interventional
Not applicable
Rochester, Minnesota, 55905, United States
Location status: Recruiting
Nicole Ron
CONTACT
Sally Olmstead
CONTACT
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Utilizing cadence alarm on a garmin device, the intervention group will attempt to increase their running cadence by 10%.
Participants will use cadence alarms to maintain preferred running cadence.
Time frame: Intake and 8 weeks
Participants will self-assess preferred running cadence using a garmin device during a 15 minute self-paced run.
Time frame: Intake, 8 weeks, and 6 month
questionnaire that assesses bowel, bladder, and pelvic symptoms and their impact on quality of life.
Time frame: intake, 8 weeks, and 6 months
6 item urinary incontinence questionnaire
Time frame: intake, 8 weeks, and 6 months
Self reported, short and simple tool to evaluate the frequency, severity and impact of urinary incontinence in men and women
Time frame: 8 weeks and 6 months
Scale allowing patient to self-report perceived change of UI symptoms
Contact information is provided by the study sponsor or research team.
Mayo Clinic
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07501065
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Miami, Florida, United States
View Trial DetailsNCT06161506
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Bethesda, Maryland, United States
View Trial DetailsNCT04133675
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Royal Oak, Michigan, United States
View Trial DetailsNCT04829175
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
New Haven, Connecticut, United States
View Trial Details